Target intelligence / Profile preview

Multiple endogenous metabolic enzymes

Molecular classification
Enzyme
01

Overview

Multiple endogenous metabolic enzymes are the diverse group of proteins responsible for catalyzing the biochemical reactions that sustain life. These enzymes facilitate essential processes such as the breakdown of nutrients for energy and the synthesis of complex molecules required for cellular structure and function (UniProt). In a therapeutic context, this category often includes drugs that provide a combination of enzymes, such as pancrelipase for digestive support, or therapies that broadly influence metabolic flux (StatPearls). Because metabolic pathways are frequently dysregulated in conditions like cancer, diabetes, and rare genetic disorders, these enzymes represent a major class of therapeutic targets (Nature Reviews Drug Discovery). However, the use of this broad classification as a specific drug target is often considered imprecise, as it encompasses numerous distinct proteins and pathways. This lack of specificity can complicate the evaluation of a drug's safety profile, particularly regarding potential off-target effects and complex interactions within the body's metabolic network (PubMed).

Other names
Metabolic enzymesEndogenous enzymesMetabolic pathway enzymesDigestive enzymes
02

Mechanism of action

The mechanism of action involves either the exogenous replacement of deficient enzymes (enzyme replacement therapy) to restore metabolic pathways or the pharmacological modulation of enzyme activity to alter metabolite concentrations and restore physiological balance.

03

Biological functions

MetabolismCellular homeostasisEnergy productionBiochemical catalysisNutrient processing
04

Disease associations

Metabolic diseaseCancerInborn errors of metabolismExocrine pancreatic insufficiencyCardiovascular disease
05

Safety considerations

Immunogenicity and anti-drug antibody formationSystemic metabolic imbalanceDrug-drug interactionsHypersensitivity and anaphylaxisOff-target enzymatic inhibition
06

Interacting drugs

Pancrelipase

5 more in the full profile.

07

Biomarkers

Serum metabolite concentrationsEnzyme activity levelsPlasma amino acid profilesUrinary organic acidsFecal fat excretion

Beyond the preview

Go deeper on Multiple endogenous metabolic enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple endogenous metabolic enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call